Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Am J Gastroenterol ; 96(7): 2194-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11467652

ABSTRACT

OBJECTIVE: Historical clinical studies suggest the potential for insect-borne transmission of human hepatitis viruses. Studies of hepatitis B virus (HBV) persistence in insects were performed before the advent of molecular techniques, and studies to assess possible insect-borne transmission of hepatitis viruses have not yet been performed. The aim of this study was to determine, using molecular techniques, whether HBV and hepatitis C virus (HCV) persist in and are excreted in the feces of the bedbug Cimex lectularius L. and kissing bug Rodnius prolixus after an infectious meal. METHODS: Blood-feeding insects from the insect order Hemiptera (Cimex lectularius L. and Rhodnius prolixus) were fed on blood from infected patients with high titers of HBV, HCV, and control uninfected patients. Insects and insect excrement were collected at weekly intervals and tested for HBV DNA and HCV RNA using the polymerase chain reaction. RESULTS: HBV DNA was detected in bedbugs and excrement up to 6 wk after feeding on an infectious meal. HBV DNA was also detected in most kissing bugs and excrement up to 2 wk after feeding. HCV RNA was not detected in bedbugs at any time after feeding. CONCLUSIONS: We did not detect HCV RNA in bedbugs after feeding on an infectious meal. Our data provide molecular evidence to suggest that HBV may persist in Hemiptera. Additional studies are ongoing to determine whether this viral persistence is capable of infection.


Subject(s)
Bedbugs/virology , Hepacivirus/isolation & purification , Hepatitis B virus/isolation & purification , Hepatitis, Viral, Human/transmission , Insect Vectors/virology , Rhodnius/virology , Animals , DNA, Viral/analysis , Feces/virology , Hepacivirus/genetics , Hepatitis B/transmission , Hepatitis B virus/genetics , Hepatitis C/transmission , Humans , RNA, Viral/analysis
2.
Viral Immunol ; 13(4): 521-31, 2000.
Article in English | MEDLINE | ID: mdl-11192299

ABSTRACT

We examined the proliferative responses of peripheral blood mononuclear cells obtained from 60 untreated patients who were seropositive by enzyme immunoassay, but negative for hepatitis C virus (HCV) RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). We used second- and third-generation recombinant immunoblot assay (RIBA) for further serological characterization. In vitro HCV-specific proliferative responses of mononuclear cells were compared to those of both untreated chronic HCV patients and patients who showed sustained virological response to interferon-alpha monotherapy, in order to assess the relative contribution of the immune response to the eradication of HCV. We found that frequency of responses to nonstructural proteins showed statistically significant differences, which were attributable to vigorous, polyspecific responses by cells from the RIBA-positive patients. In this group, core-specific proliferation was significantly associated with intravenous drug use as route of acquisition. Both other patient groups and the RIBA-indeterminate patients showed indistinguishable frequencies of proliferative responses. No association was detected between residual humoral responses, as determined from the RIBA results, and elapsed time since infection. The frequency of antibodies to NS5 differs between spontaneous cure and chronically infected patients. Cell-mediated and humoral immunity appear to be maintained in this population of patients.


Subject(s)
Hepacivirus/immunology , Hepatitis C Antibodies/blood , Hepatitis C/immunology , Lymphocyte Activation , Adolescent , Adult , Child , Female , Hepacivirus/isolation & purification , Hepatitis C/drug therapy , Hepatitis C/virology , Hepatitis C, Chronic/immunology , Humans , Immunoblotting , Immunoenzyme Techniques , Interferon-alpha/therapeutic use , Liver/virology , Male , RNA, Viral/analysis , RNA, Viral/blood , Recombinant Proteins/immunology , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Substance Abuse, Intravenous/complications , Time Factors , Viral Nonstructural Proteins/immunology , Viral Proteins/immunology
3.
J Neurosci Res ; 46(4): 438-44, 1996 Nov 15.
Article in English | MEDLINE | ID: mdl-8950703

ABSTRACT

We previously reported that recovery of Lewis rats from experimental autoimmune encephalomyelitis (EAE) is associated with the appearance of suppressor T cells (Ts). These Ts secrete TGF-beta which down-regulates the production of inflammatory cytokines by the effector T cells that mediate this disease. In the present study, we immunized Lewis rats with myelin basic protein (MBP)+CFA, and evaluated purified T cells and MBP-activated spleen cells (SpC) during the paralytic phase (day 12) and after recovery (days 30-33) for TGF-beta and interferon (IFN)-gamma mRNA. We used reverse transcriptase-polymerase chain reaction (RT-PCR), quantitated on the basis of beta-actin mRNA. Abundant IFN-gamma mRNA was present in MBP-activated SpC obtained on day 12. In contrast, only trace IFN-gamma mRNA was detected in day 30 activated SpC, and no IFN-gamma mRNA was present in purified, nonactivated T cells obtained at either time. The level of IFN-gamma mRNA correlated with secretion of IFN-gamma as determined by ELISA on SpC culture supernatants, and with severity of adoptively transferred EAE by the activated SpC. Thus, it appears that IFN-gamma mRNA is both transcribed and translated in response to antigen activation, resulting in secretion of IFN-gamma by the disease-inducing Te. In contrast, when we used RT-PCR to investigate the expression of TGF-beta mRNA, we found the transcript present in isolated T cells and MBP-activated SpC obtained from rats at both days 12 and 30. The presence of TGF-beta mRNA at time points corresponding to both clinical EAE and recovery suggests post-transcriptional regulation of the production of this immunoregulatory cytokine.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/genetics , Gene Expression Regulation , Interferon-gamma/biosynthesis , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta/biosynthesis , Acute Disease , Animals , Cells, Cultured , Convalescence , Female , Interferon-gamma/genetics , Lymphocyte Activation , Polymerase Chain Reaction , RNA, Messenger/biosynthesis , Rats , Rats, Inbred Lew , Spleen/immunology , Transforming Growth Factor beta/genetics
6.
Eur J Immunol ; 17(1): 21-6, 1987 Jan.
Article in English | MEDLINE | ID: mdl-2434338

ABSTRACT

A modified splenic fragment assay was used to assess the role of antigen-specific helper T cells in B cell isotype expression. Limiting numbers of carrier-specific helper T cells from lines or clones were injected along with a source of B cells into lethally irradiated unprimed recipients. The incidence of lodging of the T cell lines in recipient spleens at 18 h was determined by autoradiography to be 1.5 to 4.3% of the injected cells. These T cells were necessary and sufficient for the generation of T-dependent B cell responses within splenic fragments cultured in vitro with specific antigen. A comparison of isotypic responses from splenic and Peyer's patch B cells generated with the same T cell population revealed that a high proportion of the response from Peyer's patch B cells consisted of IgA antibody exclusively (46-57%) while the percentage of such responses from splenic B cells was much lower (7-10%). Thus, the isotype pattern of the response reflected the B cell source. Experiments in which cloned hemocyanin-specific T cells provided help to T-depleted spleen cells within splenic fragments from athymic recipients indicated that a single specificity of helper T cell is both necessary and sufficient to support the generation of antibody responses consisting of multiple isotypes. Isotype-specific T cells do not appear to be required in this system.


Subject(s)
B-Lymphocytes/immunology , Immunoglobulin Isotypes/biosynthesis , Lymphocyte Cooperation , T-Lymphocytes, Helper-Inducer/immunology , Animals , Cell Line , Cells, Cultured , Chemotaxis, Leukocyte , Epitopes/immunology , Hemocyanins/immunology , Immunization, Passive , Mice , Mice, Inbred BALB C/immunology , Mice, Nude/immunology , Peyer's Patches/cytology , Peyer's Patches/immunology , Radiation Chimera , Spleen/cytology , Spleen/immunology , Spleen/transplantation , T-Lymphocytes, Helper-Inducer/transplantation
7.
J Immunol ; 131(2): 533-5, 1983 Aug.
Article in English | MEDLINE | ID: mdl-6602836

ABSTRACT

The ontogeny of IL 2-responsive cells in the thymus of CBA/J mice was examined in neonatal animals and in fetuses at 14, 16, and 18 to 20 days gestation. The thymocytes were tested for responsiveness to 2 micrograms/ml Con A, TCGF, IL 2, and co-stimulation by Con A plus TCGF or IL 2. These responses were compared with those of thymocytes of 6- to 8-wk-old CBA/J. Thymocytes (1 X 10(5)) were cultured, and the reaction was measured at maximum response (96 hr). Neonatal animals gave an unusually high response to TCGF or partially purified IL 2 alone, approximately five times greater than the adult. A low but significantly enhanced proliferation, stimulated by partially purified IL 2 alone, was observed with 14-day fetal thymocytes, even though cultures of these cells in medium alone had higher background proliferation than any other age tested. In the co-stimulator reaction, proliferation significantly above background was measured at 16 days of gestation with Con A plus TCGF. The magnitude of the co-stimulator reaction increased with age, especially between the 16th and 18th day of gestation and immediately after birth.


Subject(s)
Interleukin-2/physiology , Thymus Gland/embryology , Animals , Cell Division/drug effects , Concanavalin A/pharmacology , Female , Mice , Mice, Inbred CBA , Pregnancy , Thymus Gland/cytology
10.
Diabetes ; 30(3): 242-6, 1981 Mar.
Article in English | MEDLINE | ID: mdl-6781959

ABSTRACT

Previous work from our laboratory has indicated that the transplantation of pancreatic islets is a feasible approach to the problem of diabetes. A major obstacle to transplantation is presented by passenger leucocytes, which contaminate the preparations and can lead to the prompt rejection of fresh islets. We have extended our previous studies on the rejection of islet allografts by challenging transplanted animals with enriched lymphoid cell populations prepared from animals both syngeneic to the transplanted islets and third party. Rapid and complete rejection was observed when the challenge peritoneal exudate cell population was syngeneic with the transplanted islets; rejection was determined by both functional and histologic criteria. Peritoneal exudate cells from a third-party rat strain induced delayed and variable effects upon the function of the transplant. In contrast, splenic T-cells were capable of inducing rejection, regardless of the strain of origin, though the time course of T-cell-induced rejection was slower than that observed by syngeneic peritoneal exudate cells. Finally, splenic B-cells completely failed to induce rejection. Our data indicate that at least two mechanisms exist by which the rejection of islet allografts may be triggered. The first is a haplotype-specific mechanism initiated by a cell type present at high frequency in peritoneal exudate cells; these are probably macrophages. The second mechanism is initiated by immunocompetent T-cells; this mechanism shows no haplotype specificity. We suggest that both macrophages and T-cells must be considered when devising protocols for the removal of passenger leucocytes from allografts.


Subject(s)
Graft Rejection , Islets of Langerhans Transplantation , Macrophages/immunology , T-Lymphocytes/immunology , Animals , Ascitic Fluid/cytology , B-Lymphocytes/immunology , Diabetes Mellitus, Experimental/therapy , Islets of Langerhans/pathology , Liver/pathology , Male , Rats , Spleen/cytology , Transplantation, Homologous
11.
J Exp Med ; 152(5): 1135-46, 1980 Nov 01.
Article in English | MEDLINE | ID: mdl-6776225

ABSTRACT

We describe the identification of a monoclonal antibody that recognizes a determinant on the delta chain of mice of the Iga, allotype groups. The monoclonal Ig in soluble form induces allotype-specific proliferation by splenic B lymphocytes from normal animals of these haplotypes. Spleen cells from mice bearing the X-linked defect of CBA/N mice fail to respond, although they bear the determinant. Proliferation is independent of T lymphocytes. The data indicate a direct triggering function for sIgD.


Subject(s)
B-Lymphocytes/immunology , Immunoglobulin Allotypes/immunology , Receptors, Antigen, B-Cell/immunology , Animals , Immunoglobulin D/immunology , Immunoglobulin G/immunology , Immunoglobulin Heavy Chains/immunology , Immunoglobulin delta-Chains/immunology , Mice , Mice, Inbred Strains
12.
J Exp Med ; 147(3): 814-29, 1978 Mar 01.
Article in English | MEDLINE | ID: mdl-416168

ABSTRACT

Spleen cell cultures from young adult mice of a variety of strains were stimulated to incorporate tritiated thymidine ([3H]TdR) by a goat anti-mouse IgM antiserum and by purified anti-mu antibodies prepared from this serum. This stimulation was shown to depend upon the anti-mu activity of the antiserum. In addition, ultracentrifuged anti-mu and F(ab')2 fragments of anti-mu were shown to be stimulatory. The anti-mu preparation lacked detectable endotoxin contamination and was also shown to stimulate response by two strains (C57BL/10ScCr and C3H/HeJ) which are unresponsive to the mitogenic effects of endotoxin, while it failed to stimulate a response by cells from a mouse strain (CBA/N) which responds to endotoxin. In addition purified goat anti-mouse gamma, kappa antibodies and rabbit anti-mouse kappa-antib odies stimulated uptake of [3H]TdR by mouse spleen cells, although to a lesser degree than the anti-mu preparation. The cell density, culture requirements, and kinetics of the response are presented.


Subject(s)
Antibodies, Anti-Idiotypic , Immunoglobulin Heavy Chains , Immunoglobulin mu-Chains , Lymphocyte Activation , Receptors, Antigen, B-Cell , Animals , Antibodies, Anti-Idiotypic/isolation & purification , Chromatography, Affinity , Dose-Response Relationship, Immunologic , Immunoglobulin Fab Fragments , Immunoglobulin kappa-Chains , Kinetics , Mice , Polysaccharides, Bacterial/pharmacology , Structure-Activity Relationship
14.
J Exp Med ; 146(6): 1707-18, 1977 Dec 01.
Article in English | MEDLINE | ID: mdl-72781

ABSTRACT

An alloanti-delta antibody was prepared by immunizing C57BL/Ka mice with BALB/c spleen cells. Its specificity for delta-chain was demonstrated by immunoprecipitation and SDS-PAGE of 125I-labeled membrane proteins from BC8 spleen cells. BC8 mice possess C57BL/Ka "background" genes and BALB/c IgH genes. The anti-delta reagent without complement inhibited the primary in vitro anti-TNP antibody response to TNP-AECM-Ficoll by BC8 spleen cells, although it had no effect of the anti-TNP response of congenic C57BL/Ka spleen cells, which lack the delta-allotype identified by this antibody. On the other hand, the anti-delta antibody had no effect on the anti-TNP response of BC8 spleen cells to TNP-BA, except at limiting antigen concentrations. Both TNP-AECM-Ficoll and TNP-BA are T-I antigens, but they differ in that TNP-AECM-Ficoll fails to stimulate in vitro responses by immunologically defective CBA/N and neonatal spleen cells whereas TNP-BA can cause responses from both these animals. These results suggest that the IgD receptor is critical to T-I antibody responses initiated by TNP-AECM-Ficoll but that it is not required for T-I responses stimulated by TNP-BA.


Subject(s)
B-Lymphocytes/immunology , Receptors, Antigen, B-Cell/physiology , Animals , Antibody Formation , Antigens , Epitopes , Immunoglobulin D/physiology , Mice , Mice, Inbred C57BL
16.
Fed Proc ; 35(10): 2195-201, 1976 Aug.
Article in English | MEDLINE | ID: mdl-1084836

ABSTRACT

The operation of clonal selection for cells of the B-lymphocyte line is discussed with regard to: 1) The clonal repertoire determined by antigen binding to B lymphocytes, which is much larger than that determined by limiting dilution cloning assays. This quantitative difference is interpreted in terms of the multiple shared specificities of each antibody molecule. 2) Multiclonal responses and initial selection by antigen of particular clones (preferential primary selection). 3) Clonal dominance. During an immune response one clone (or a small number of clones) of B cells is preferentially selected and proliferated, apparently at random, from a heterogeneous population of cells capable of responding to the given antigen. Co-dominance of two or more clones simultaneously can be obtained by mixing selected clones. Secreted antibody is seen as playing a role in the establishment of clonal dominance. A model for clonal expansion is presented. The model attempts to explain the generation of memory and antibody secreting cells within each clonal expansion in terms of the ratio of two signals, one for proliferation and one for differentiation. The delivery of these signals is proposed to involve the receptor antibody-antigen interaction for proliferation and a self-recognition site interaction for differentiation.


Subject(s)
Antibody-Producing Cells/immunology , B-Lymphocytes/immunology , Clone Cells/immunology , Selection, Genetic , Antibodies , Antibody Formation , Antibody Specificity , Antibody-Producing Cells/cytology , Antigens , B-Lymphocytes/cytology , Cell Differentiation , Genes , Histocompatibility Antigens , Immunologic Memory , Models, Biological , Receptors, Drug , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...